Reducing the melioidosis burden: public health, chronic disease prevention, or improved case management?

Affiliations

¹ The Peter Doherty Institute for Infection and Immunity, University of Melbourne and the Royal Melbourne Hospital, Melbourne, VIC 3000, Australia; Infectious Diseases Department, Austin Hospital, Melbourne, VIC, Australia. Electronic address: katherine.gibney@unimelb.edu.au.
² School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia; Infection Prevention and Healthcare Epidemiology Unit, Alfred Health, Melbourne, VIC, Australia.

Comment

Katherine B Gibney et al. Lancet Infect Dis. 2019 Aug.

. 2019 Aug;19(8):800-802.

doi: 10.1016/S1473-3099(19)30303-2. Epub 2019 Jul 5.

¹ The Peter Doherty Institute for Infection and Immunity, University of Melbourne and the Royal Melbourne Hospital, Melbourne, VIC 3000, Australia; Infectious Diseases Department, Austin Hospital, Melbourne, VIC, Australia. Electronic address: katherine.gibney@unimelb.edu.au.
² School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia; Infection Prevention and Healthcare Epidemiology Unit, Alfred Health, Melbourne, VIC, Australia.

No abstract available

Comment on

Global burden of melioidosis in 2015: a systematic review and data synthesis.
Birnie E, Virk HS, Savelkoel J, Spijker R, Bertherat E, Dance DAB, Limmathurotsakul D, Devleesschauwer B, Haagsma JA, Wiersinga WJ. Birnie E, et al. Lancet Infect Dis. 2019 Aug;19(8):892-902. doi: 10.1016/S1473-3099(19)30157-4. Epub 2019 Jul 5. Lancet Infect Dis. 2019. PMID: 31285144 Free PMC article.